LeaderPortfolio
Kiani
Joe Kiani
Rank #2971
UNITED STATEShealthcareMedical devices

Joe Kiani

Net Worth
$1.255B
+0.05% (24h)
Joe Kiani, an Iranian-born American, is a prominent figure in the medical technology industry, best known as the founder of Masimo, a company specializing in medical devices. His estimated net worth is $1.2 billion, sourced from his successful ventures in the healthcare sector. Kiani's career has been marked by significant achievements, including the co-invention of Masimo SET Pulse Oximetry, a technology that has saved countless lives and revolutionized patient monitoring. He holds several patents and has been recognized with numerous awards for his contributions to patient safety and innovation. Kiani's commitment extends beyond business, as he actively participates in philanthropy and civic engagement, demonstrating his dedication to improving healthcare and the well-being of others.

The Full Dossier

Early Life

Joe Kiani was born in Shiraz, Iran, on September 16, 1964. At the age of nine, he immigrated to the United States with his family. His father was an engineer, and his mother was a nurse. Kiani graduated from high school at 15 and later pursued higher education, earning bachelor's and master's degrees in electrical engineering from San Diego State University (SDSU) by age 22.

Rise to Success

Kiani's career began with engineering roles at Burroughs and Bell Industries. In 1989, he founded Masimo, a medical technology company that would become a global leader in non-invasive patient monitoring. Kiani's vision was to improve patient care by developing more accurate and reliable monitoring technologies. Masimo's Signal Extraction Technology (SET) pulse oximetry, co-invented by Kiani, addressed critical limitations of traditional pulse oximetry, leading to a significant reduction in false alarms and improved patient outcomes. The company went public in 2007 and is listed on the NASDAQ under the ticker MASI. Kiani was ousted from Masimo's board and resigned as CEO in September 2024 after a dispute with activist investors.

Key Business Strategies

Masimo's success can be attributed to Kiani's focus on innovation and the development of proprietary technologies. The company's initial business model focused on developing and licensing its Signal Extraction Technology (SET) to major medical device manufacturers, which enabled rapid market reach. Masimo's products have been widely adopted in hospitals and healthcare settings globally.

Philanthropy

Kiani is committed to patient safety and has established the Patient Safety Movement Foundation. He has served on the Board of Trustees of the California Institute of Technology (Caltech), the Board of Councilors of the Carter Center, and the Chair of the Board Quality Committee of the Children's Hospital of Orange County (CHOC). Kiani has also been involved in various civic engagement platforms, including A Starting Point, a video-based platform.

Career Timeline

2024

Resigned as CEO of Masimo

Kiani resigned as CEO after losing a board seat.

2021

Appointed to PCAST

Appointed by President Joe Biden to serve on the President's Council of Advisors on Science and Technology (PCAST).

2007

Masimo Goes Public

Masimo became a publicly traded company on NASDAQ (MASI).

1995

FDA Clearance for Masimo SET

Masimo's Signal Extraction Technology (SET) pulse oximetry received FDA clearance.

1989

Founded Masimo

Joe Kiani founded Masimo, a medical technology company that revolutionized patient monitoring.

Philanthropic Impact

Patient SafetyUndisclosed

Patient Safety Movement Foundation

Founded the Patient Safety Movement Foundation to eliminate preventable medical errors.

Wealth Trajectory